We stained the 164 NSCLC samples with the antibodies against CD20 and CD79A and evaluated the infiltration level of naïve-like B cells by using the ratio of CD20+CD79A+-positive cells in TILs. Here, CD79A is linked to non-small cell lung carcinoma.